Cargando…
Pediatric electronic cigarette or vaping product use–associated lung injury (EVALI): updates in the coronavirus disease 2019 (COVID-19) pandemic era
Electronic cigarette or vaping product use–associated lung injury (EVALI) is a toxic inhalational injury that surged in late 2019 and early 2020, immediately prior to the coronavirus disease 2019 (COVID-19) pandemic. Although EVALI cases have significantly decreased, they are still encountered, espe...
Autores principales: | Friedman, Jonathan, Schooler, Gary R., Kwon, Jeannie K., Artunduaga, Maddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388356/ https://www.ncbi.nlm.nih.gov/pubmed/35982339 http://dx.doi.org/10.1007/s00247-022-05454-z |
Ejemplares similares
-
The EVALI outbreak and vaping in the COVID-19 era
por: The Lancet Respiratory Medicine
Publicado: (2020) -
Extracorporeal support to treat E-cigarette or vaping product use-associated lung injury (EVALI) during the coronavirus disease 2019 (COVID-19) pandemic
por: Hayanga, J.W. Awori, et al.
Publicado: (2020) -
Chemical Constituents Involved in E-Cigarette, or Vaping Product Use-Associated Lung Injury (EVALI)
por: Muthumalage, Thivanka, et al.
Publicado: (2020) -
Electronic Cigarette or Vaping Product Use-Associated Lung Injury: A Case Report
Publicado: (2021) -
Electronic Cigarette or Vaping-Associated Lung Injury Manifested as Acute Eosinophilic Pneumonia: A Case Report
Publicado: (2023)